Bristol-Myers Squibb's Earnings Outlook
Portfolio Pulse from Benzinga Insights
Bristol-Myers Squibb (NYSE:BMY) is expected to report an EPS of $1.54 in its upcoming quarterly earnings on 2024-02-02. Analysts and investors are keen on not just the earnings beat but also the company's guidance for future growth. Historical data shows mixed reactions to past earnings, with the stock price fluctuating post-earnings announcement. Currently, BMY shares are down 34.1% over the last 52 weeks, trading at $48.87 as of January 31.
February 01, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Bristol-Myers Squibb is anticipated to report an EPS of $1.54 for the upcoming quarter, with a focus on future guidance. The stock has seen a 34.1% decline over the past year, trading at $48.87 as of the last update.
The expected EPS and the emphasis on future guidance are crucial for investors, especially given the stock's 34.1% decline over the past year. Historical performance shows that earnings announcements have led to mixed stock price reactions, indicating a potentially neutral short-term impact. The company's past ability to beat EPS estimates could be a positive sign, but the overall negative trend in stock performance and the importance of future guidance suggest a cautious outlook.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100